Skip to content
AwardedSpainGoods€1,831,680

Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabtagen Vicleucel), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal

Published
Published 26 January 2026

Overview

Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabtagen Vicleucel), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€1,831,680
Procedure
Direct
Published
26 January 2026
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
€1,831,680
Award date
23 December 2025
Winner
  • BRISTOL MYERS SQUIBB S.A.U.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    26 January 2026

Contracting authority

  • HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

    Procuring entity

    Madrid, Spain

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabtagen Vicleucel), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal — won by BRISTOL MYERS SQUIBB S.A.U. — Skim